UTI - Healthcare Fund
This is the Direct plan of UTI - Healthcare Fund — bought from the fund house, with no distributor commission in its expense ratio. Income is retained in the fund, so it shows up as NAV rather than as a payout.
Performance
Scorecard
★★★★☆4/5 vs 145 of 257 Sectoral/ Thematic peers- Performance 60%
- Risk 15%
- Cost 10%
- Downside 15%
How this is computed
Each verdict is computed from this fund's own metrics against its sub-category — the number behind it is shown, not a black-box rating. The stars weight the same ground 60/15/10/15 (performance/risk/cost/downside) across every fund in the peer group. Ranked within Sectoral/ Thematic (same plan and option). 145 of the 257 Sectoral/ Thematic funds in this cohort carry the full record the stars need, so they are the ones ranked against.
3Y CAGR +23.08% · ranks 8 of 145 Sectoral/ Thematic funds
Volatility 13.7% vs 15.8% category avg
1.4% expense vs 1.3% category avg
83% of rolling 3Y windows were positive
Strengths & concerns
Generated from this fund's own numbers against its sub-category — each point names the figure behind it.
Strengths
- Ahead of the Sectoral/ Thematic average on 1M/3M/6M/1Y — 1Y by 16.35pp
- 3-year return (+23.08%) beats the Sectoral/ Thematic average (+14.28%)
- 5-year return (+17.75%) beats the Sectoral/ Thematic average (+12.96%)
- Ranks #11 of 238 on 1-year return in its Sectoral/ Thematic cohort
- Stronger risk-adjusted returns — Sharpe 1.21 vs 0.48 Sectoral/ Thematic average
Concerns
No significant concerns identified.
Key Metrics
Scheme Info
DefinitionsPeriod returns (<1Y, absolute — not annualized)
DefinitionsAnnualized returns (≥1Y — CAGR)
DefinitionsAdvanced metrics — risk and benchmark ratios
Fund vs category average (Sectoral/ Thematic)
| Period | Fund | Category avg. | Diff |
|---|---|---|---|
| 1M abs | +10.51% | +6.15% | +4.36% |
| 3M abs | +2.79% | +0.56% | +2.23% |
| 6M abs | +13.20% | +7.94% | +5.26% |
| 1Y CAGR | +22.03% | +5.68% | +16.35% |
| 3Y CAGR | +23.08% | +14.28% | +8.80% |
| 5Y CAGR | +17.75% | +12.96% | +4.79% |
Category average across peers in Sectoral/ Thematic (up to 257 funds with data), same plan and option, excluding this fund. Under-1-year figures are absolute; 1Y and beyond are annualised (CAGR).
Not sure what a figure means? The glossary explains every metric, and the methodology shows the formulas.
Category rank
Vs 257 peers in Sectoral/ Thematic
Backtest this fund
What a SIP or one-time investment would have grown to over this fund’s real NAV history.
60 monthly installments of ₹10,000 into UTI - Healthcare Fund, valued at the latest NAV. XIRR annualizes for each installment’s timing.
Calendar-year returns
What the fund actually returned in each year, not the smoothed average.
| Year | Fund | Nifty Healthcare TRI | Diff | |
|---|---|---|---|---|
| 2026part | +23.98% | +19.00% | +4.98% | |
| 2025 | -2.18% | -1.53% | -0.65% | |
| 2024 | +44.27% | +41.34% | +2.93% | |
| 2023 | +39.56% | +33.89% | +5.67% | |
| 2022 | -11.30% | -10.17% | -1.13% | |
| 2021 | +20.35% | +19.01% | +1.34% | |
| 2020 | +68.92% | — | — | |
| 2019 | +2.17% | — | — | |
| 2018 | -6.54% | — | — | |
| 2017 | +7.18% | — | — |
January–December, from this fund's NAV history. Absolute return, not annualised. “part” marks a year the fund didn't run end to end — its first year, the current year so far, or one it stopped reporting in; those years show no benchmark comparison.
Taxation
Taxed as equityThis is an equity-oriented fund (≥65% in Indian equities), so gains get the concessional capital-gains rates below — they do not add to your income-tax slab.
Flat, on the whole gain
On gains above ₹1.25 L per financial year
Applies to capital gains on redemption. Excludes IDCW/dividend tax, STT, surcharge and cess, and pre-2018 equity grandfathering. For research only — consult a tax advisor before filing.
Asset allocation
As on 31 Oct 2026 · AMC disclosure- Equity97.99%
- Cash & Equivalents1.99%
Fund size over time
Quarterly average AUM · AMFIAt or near its largest, ₹1,399Cr in July - September 2026. Size matters most where the mandate is narrow — a large small-cap or a very large flexi-cap book is harder to move without moving the price.
Net flow is an estimate: AMFI publishes a quarterly average AUM, not a closing balance, and it covers every plan and option of this scheme together, so it is a read on direction and rough size rather than a cash-flow statement.
AMC Profile
UTI Mutual Fund descends from the Unit Trust of India, which was effectively the whole Indian mutual fund industry from 1963 until private managers were allowed in. It was carved out as a SEBI-registered fund house in 2003, is listed on the exchanges, and is held by SBI, LIC, Bank of Baroda, PNB and T. Rowe Price rather than a single parent.
Fund Managers
KGKamal GadaStart date not disclosed
Senior Vice President- Equity
B.com, CA, CS, CFA
He is the Vice President - Equity. He completed CA from ICAI and has cleared Level 3 of CFA from CFA Institute, USA. He graduated in Bachelor of Commerce in 2003 from Mumbai University. He began his career with BPCL as Senior Accounts Officer in 2004. Kamal joined UTI AMC in 2008 as Research Analyst. Presently he is Fund Manager for UTI Healthcare Fund as well as covers Pharma and Chemicals sector. He has over 16 years of experience in Equity Research. May 2025
Fund manager, benchmark and dealing terms from this scheme's SEBI-filed Scheme Information Document on AMFI. Each manager's qualifications and role are reconciled across every filing this fund house makes for them, including its Statement of Additional Information. Total AUM via AMFI.
Explore from here
UTI in the news
Headlines about the fund house, not this scheme in particular — highlights only; tap through to read the full story at the source.
SBI Cards holds investor meets with Goldman Sachs, UTI MF
scanx.trade · 8h ago
Ujjivan Small Finance Bank To Participate In Investor Meetings From November 25 To December 3
Sahi · 8h ago
Kalyan Janata Sahakari Bank Recruits Contract Officers in 2026
Elets BFSI · 11h ago
Know which fund houses spend high on distributor engagement
Cafemutual · 1d ago
SBI MF leads institutional AUM; JioBlackRock has highest institutional share
Cafemutual · 1d ago
Urban Company Raises Rs 2,500 Cr Through QIP, Issue Subscribed Nearly 6 Times
TechStory · 1d ago
Samco Asset Management names Rohit Mattoo Deputy CEO
Elets BFSI · 1d ago
Urban Company shares rise 7% as Rs 2,500 crore QIP oversubscribed
Moneycontrol.com · 1d ago
Returns and risk are computed from NAV history and may differ slightly from other portals due to methodology (rolling vs point-to-point, dividend treatment). For research only — not investment advice.
About Sectoral & Thematic funds
Sectoral and thematic funds must keep at least 80% in the equity of one sector (banking, pharma, technology) or one theme (consumption, manufacturing, ESG). That concentration is the point and the risk: with no mandate to diversify away from the sector, the fund rises and falls with it.
From the blog
UTI Mutual Fund in 2026: by the numbers
27 Oct 2026
UTI MF managed ₹4,02,337 crore in July–September 2026, 7th of 55, up 6.3% in a year. 235 Direct Growth schemes, ranked on 3-year returns.
Top 15 equity funds by 5-year SIP return, October 2026
24 Oct 2026
A ₹10,000 monthly SIP for five years earned up to 20.89% a year in Bandhan Small Cap Fund. The top 15 equity funds and the best in each category.
Falls less than it rises: 74 funds, 29 pharma or hybrid
10 Oct 2026
74 funds caught over 95% of their benchmark's rising months and under 85% of its falls. 14 of 15 pharma funds pass; 3 of 97 large, mid and flexi caps do.
Frequently asked questions
What is the NAV of UTI - Healthcare Fund?
As of 19 Nov 2026, the NAV of UTI - Healthcare Fund is ₹398.73 per unit. NAV (net asset value) is the fund's per-unit price, published once each business day.
What returns has UTI - Healthcare Fund delivered?
UTI - Healthcare Fund has returned +22.03% over 1 year, +23.08% per year over 3 years, +17.75% per year over 5 years and +16.53% per year since inception. Figures beyond one year are annualised (CAGR) and are computed from AMFI NAV history, so they may differ slightly from other portals.
What is the expense ratio of UTI - Healthcare Fund?
UTI - Healthcare Fund charges an expense ratio of 1.35% per year. This annual fee is already deducted from the NAV, so the returns you see are net of it.
What are the top holdings of UTI - Healthcare Fund?
UTI - Healthcare Fund's largest holdings are SUN PHARMACEUTICALS INDUSTRIES (7.4%), DIVIS LABORATORIES LTD. (6.5%), DR REDDYS LABORATORIES LTD. (5.8%), AJANTA PHARMA LTD. (4.3%) and MAX HEALTHCARE INSTITUTE LTD (4.2%). Holdings are disclosed monthly and change over time.
How risky is UTI - Healthcare Fund?
UTI - Healthcare Fund sits at the very high level on our estimate of SEBI's risk-o-meter scale, its trailing-3Y volatility (annualised) is 13.7% and its worst peak-to-trough fall in our sample was 27.1%. Higher volatility means the NAV swings more; the drawdown shows how far it has fallen from a peak historically.
What does the Sharpe ratio of 1.21 mean?
The Sharpe ratio is return earned per unit of total risk, above a 6.5% risk-free rate. UTI - Healthcare Fund's 1.21 means it has rewarded its volatility with excess return. Higher is better.
What is the benchmark of UTI - Healthcare Fund?
UTI - Healthcare Fund is benchmarked against the BSE Healthcare TRI. The alpha, beta and capture figures on this page are measured against the Nifty Healthcare TRI, the closest index whose daily history we hold.
Who manages UTI - Healthcare Fund?
UTI - Healthcare Fund is managed by Kamal Gada at UTI.
When was UTI - Healthcare Fund launched, and what is its objective?
UTI - Healthcare Fund was launched on 28 Jun 1999. its stated objective is: The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. Both are as filed in the scheme's own Scheme Summary Document.
How is UTI - Healthcare Fund taxed?
UTI - Healthcare Fund is an equity-oriented fund, so its capital gains get concessional rates: short-term gains (units held under 1 year) are taxed at 20%, and long-term gains (held 1 year or more) at 12.5% above a ₹1.25 lakh per-year exemption. These rates apply on redemption and don't add to your income-tax slab.